Just In
- 44 min ago Arushi Sharma-Vaibhav Vishant Wedding, Love Aaj Kal 2 Actor Looks Resplendent In A Pastel Ethnic Outfit, Pics!
- 3 hrs ago What Your Tongue Reveals About Your Health: Wellness And Warning Signs You Need To Know
- 4 hrs ago How Can You Protect Yourself From Extreme Heat? Dos And Don’ts To Follow
- 8 hrs ago Daily Horoscope, 23 April 2024: Cancer Will Have A Good Day In Terms Of Finances
Don't Miss
- Movies Is Coolie A Sequel To Rajinikanth's Thee? Fans Speculate On Lokesh Kanagaraj's Next Film After Teaser Release
- Finance American Express Revamps Platinum Travel Credit Card Design
- Automobiles Log9 Unveils Amphion & Nexmile – Revolutionizing EV Asset Management
- Sports Babar Azam Fans Accused of Cyberbullying; Forces Pakistani Actress To Lock Instagram Account
- News Karnataka CM Siddaramaiah, DK Shivakumar Lead Congress Protest Over Drought Relief
- Education Students of the Canadian International School in Bangalore Raise Nearly 60 Lakh Rupees for Bangalore NGOs
- Technology Airtel Introduces New International Roaming Plans Starting at Rs 133
- Travel Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Gene Therapy
Scientists have found that a gene therapy, invented at The University of Texas M. D. Anderson Cancer Center, increases the rate of survival for patients having head and neck cancer in the end-stage.
This therapy, involving Advexin(r), a modified adenovirus that expresses the tumor-suppressing gene p53, for end-stage head and neck cancer, has been the first to succeed in a U.S. phase III clinical trial for cancer by Introgen Therapeutics, Inc.
"Cells become cancerous because p53 no longer functions. Restoring p53 works unlike any current cancer treatment because it treats the cancer genome," said Jack Roth, M.D., professor in M. D. Anderson's Department of Thoracic & Cardiovascular Surgery, who invented the drug and co-founded Introgen.
Many types of cancer involve the inactivation of the p53 gene, while normally it halts the division of a defective cell and then force the cell to kill itself.
The trial showed that p53 expression in the patient's tumor before treatment is a reliable biomarker for how to treat head and neck cancer.
It was observed that patients with a favourable p53 profile who received Advexin(r) had a median survival of 7.2 months, as against 2.7 months for those whose tumor expressed high levels of mutant p53 before treatment. Those having this unfavourable profile were better off taking the chemotherapy drug methotrexate, resulting in median survival of 5.9 months.
"The important finding is that patients who benefit from treatment can be identified with the p53 biomarker. The biomarker will enable physicians to personalize treatment," said Roth, who also directs M. D. Anderson's W.M. Keck Center for Innovative Cancer Therapies.
The trial led by John Nemunaitis, M.D., executive director of the Mary Crowley Medical Research Center at Baylor-Charles A. Sammons Cancer Center in Dallas, was conducted on 123 patients.
The researches observed that those who got treated with Advexin experienced far fewer harmful side effects such as pneumonia than those who received methotrexate. Also, the incidence of inflammation of the mouth lining and a decrease in white blood cells, also dropped to zero for those receiving Advexin.
"That certainly results in a better quality of life," noted Roth.
And this appears to be relevant as p53 does not cause problems in normal cells. And now Roth's lab has been developing gene therapy for cancer since 1990.
"We
wanted
to
go
beyond
conventional
treatment,
because
most
of
those
treatments
were
not
very
effective.
Surgery
and
radiation
are
limited
to
the
local
tumor
and
once
given,
it's
very
hard
to
repeat
those
therapies.
Chemotherapy
inhibits
DNA
replication,
but
it
also
interferes
with
normal
cells,"
said
Roth.
- kidsFirst Gene Therapy For Tay-Sachs Disease Successfully Given To Two Children
- wellnessCancer Patients Cured 10 Years After Gene Therapy Aka CAR-T Cell Therapy, Reveal Doctors
- disorders cureGene Therapy Helps Prevent Asthma - Study
- healthExclusive: Cervical Cancer In India, Doctor Shares Preacautions And Treatments That One Needs To Be Aware Of
- healthTV Actor Dolly Sohi Passes Away Due To Cervical Cancer, Know The Early Signs That Are Beyond Early Detection
- healthGhazal Maestro Pankaj Udhas Passes Away Due To Pancreatic Cancer, Know Risk Factors, Prevention, Treatments
- healthNew Study Finds Links Infertility In Men With Increased Risk Of Cancer For Them And Their Relatives
- healthIs Pancreatic Cancer Curable? Know The Causes, Warning Signs, And Treatment Of This Uncommon Silent Killer
- insyncBaba Vanga's Prophecy For 2024 May Come True With New Vaccine In Russia For Cancer
- healthDetecting Bowel Cancer: 10 Signs Of This Silent Killer To Watch Out For And Seek Medical Attention
- health10 Cancer Fighting Foods That Help That Play Significant Role In Supporting Body's Natural Defences
- healthWorld Cancer Day 2024: 5 Simple Daily Habits To Reduce The Risk Of Developing Cancer